Compare GSK plc (GSK) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs AT&T Inc. — how do they compare? GSK plc trades at $50.25 (market cap $102.60B), while AT&T Inc. trades at $24.18 (market cap $167.88B). The key difference: AT&T Inc. is the larger of the two by market cap, and AT&T Inc. pays the higher dividend (4.53%). Which is the better fit depends on your goals.
| GSK | T | |
|---|---|---|
Market Cap | $102.60B | $167.88B |
Sector | Health | Media |
52-Week High | $61.18 | $29.62 |
52-Week Low | $38.22 | $20.49 |
Enterprise Value | $123.04B | $313.20B |
Dividend Yield | 3.57% | 4.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.16, down 1.51% today, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings of $1.36 per share, beating estimates, and announced a $2.52 billion cost-saving plan to accelerate drug development. Revenue growth remains steady, with 2025 revenue at $32.67 billion and net income of $5.72 billion, though profit margins have fluctuated in recent years.
Outlook is positive with continued earnings beats and strategic investments, but risks include competitive pressures and regulatory uncertainties. Analyst sentiment is mixed with 31% buy ratings, 55% hold, and 14% sell, reflecting cautious optimism amid execution risks and market volatility.
AT&T (T) trades at $24.19, up 0.46% today, with a bullish technical signal from moving averages but overbought short-term RSI. The company shows strong fundamentals with a P/E of 8.09, net income margin of 16.94%, and consistent earnings beats in recent quarters. Recent news highlights its focus on fiber expansion and AI integration, while cash flow improved to $15.12B net in 2025.
Outlook is positive with a consensus price target of $27.69, offering 14.5% upside, supported by a 4.8% dividend yield. Risks include competitive pressure from SpaceX's Starlink and high debt levels. Analysts are mixed but lean bullish, with 41% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
